Cell and gene therapy

mRNA vaccines
#Biologics #Biotechnology #Cell and gene therapy #Contract development and manufacturing organisations #Covid-19 #mRNA #Vaccines

Preparing for new-era drug modalities with technology 

Listen to this article on the DDW podcast: Samsung Biologics’ Senior Vice President, James Park, explores the opportunities emerging for CDMOs to support mRNA developers as they explore new therapeutic areas for patients.  Prior to the pandemic, messenger RNA (mRNA) drug development was niche and predominantly pointed at different disease targets,… Read More

#Exclusive Content

#Biologics #Bioproduction #Bioseparation #Cell and gene therapy #Purification technology

How to achieve greener, faster and more cost-effective bioprocessing workflows 

Astrea Bioseparations has launched its Nereus LentiHERO lentiviral vector (LVV) purification technology commercially. Incorporating AstreAdept, the company’s proprietary nanofiber material, this solution has been created to address the challenges associated with purifying the large and fragile products used in cell and gene therapy. AstreAdept is a proprietary bioseparations material that… Read More

#News

#ALS #Alzheimer's #Biomarkers #Breast cancer #Cell and gene therapy #Head and neck cancer #Ice Bucket Challenge #Manufacturing #Neurodegenerative disorders #Oncology #Ophthalmology

This week in drug discovery (3-7 October)

News round-up for 3-7 October by DDW Digital Content Editor Diana Spencer This week has brought new trial results and regulatory approvals shedding light and bringing hope into therapy areas of unmet need. The University of Birmingham and… Read More

#News

#Automation / robotics #Cell and gene therapy #Drug Discovery 2022 #Drug screening #ELRIG #Preclinical investigations #Sustainability

The trends driving ELRIG Drug Discovery 2022

DDW Editor Reece Armstrong explores some of the trends that will be featured in sessions throughout ELRIG Drug Discovery 2022 and the news behind them. Taking place at the ExCel in London from 4-5 October, ELRIG Drug Discovery 2022 is set to provide visitors with access to the latest trends, technologies and… Read More

#Exclusive Content

#Biologics #Cell and gene therapy #Malaria #Manufacturing #Oncology

This week in drug discovery (26-30 September)

This week in drug discovery (26-30 September) News round-up by DDW Editor Reece Armstrong. An interesting week across the board for the pharma sector with the first biologic for severe asthma approved in the EU. Elsewhere researchers have discovered new ways of  identifying cancer cells and a manufacturing system could… Read More

#News

#Cell and gene therapy #Manufacturing

Cell analysis system could streamline gene therapy manufacturing 

PerkinElmer has launched the Cellaca PLX Image Cytometry System, a first-of-its-kind benchtop platform that enables researchers to assess multiple Critical Quality Attributes (CQAs) of cell samples in a single automated workflow, including cell identity, quality and quantity.  The system, designed by the company’s Nexcelom unit, combines best-in-class… Read More

#News

Cell therapy platform
#Automation / robotics #Biotechnology #Cell and gene therapy #Cell therapy

Platform enables cell therapy commercialisation

Terumo Blood and Cell Technologies (BCT) has launched the Quantum Flex Cell Expansion System, a bioreactor platform that supports process development through to commercial manufacturing for the cell and gene therapy (CGT) sector.   Responding to the industry’s need for earlier automation to potentially limit additional and… Read More

#News

Quantum Flex
#Bioreactor #Cell and gene therapy #Cell expansion #Cell manufacturing

New platform could streamline cell manufacturing

A new bioreactor platform that aims to support the cell and gene therapy (CGT) sector from process development to commercial manufacturing has been launched. The Quantum Flex Cell Expansion System has been created by medical technology company Terumo Blood and Cell Technologies (Terumo BCT). Using the system, developers can complete… Read More

#News

#Advanced Therapy Medicinal Products (ATMPs) #Biopharma #Cell and gene therapy #Cell and Gene Therapy Catapult

Cell and gene therapy – where is the innovation? 

Where globally is innovation occurring and what factors - industry, regulatory, and academia - are helping developers get their products to market? Here, DDW Editor Reece Armstrong explores the global hubs of innovation for cell and gene therapies. Since the approval of Kymirah in 2017, the cell and gene therapy… Read More

#Exclusive Content

#Advanced Therapies #Cell and gene therapy

Cell and gene therapies: Opportunities for innovation 

Listen to this article on the DDW Podcast: By Dr. Deborah Phippard, Chief Scientific Officer of Precision for Medicine and Anshul Mangal, President & General Counsel of Project Farma.  In recent years the advanced therapy industry has been the most significant disruptor in medicine. Cell and gene therapies are not only… Read More

#Exclusive Content #Opinion

#Cell and gene therapy #Covid-19 #Drug discovery #Manufacturing

The challenges and trends of cell & gene therapies 

DDW Editor Reece Armstrong looks at the cell and gene therapy landscape, examining the challenges facing developers and the trends we can expect to see throughout the year.   There’s no doubt that cell and gene therapies present some of the most exciting opportunities for emerging drugs. This area of medicine, which… Read More

#Exclusive Content #Opinion #Trends & Analysis

#Advanced Therapies #Cell and gene therapy #Events #Gene therapy #Phacilitate

What to expect from Advanced Therapies Europe 2022

The Phacilitate Advanced Therapies Europe 2022 conference will take place from 30 August to 1 September at the Royal Lancaster in London, UK. The conference is the European twin to Phacilitate Advanced Therapies Week, an event held in January in Florida, US. The event is tailored to a European audience… Read More

#Exclusive Content

#Cell and gene therapy #Clinical trials #Oncology

Sitting down with Calidi Biotherapeutics

Listen to this article on the DDW Podcast: Dr Boris Minev, President of Medical and Scientific Affairs at Calidi Biotherapeutics speaks to DDW’s Reece Armstrong about the company’s approach to treating cancer. RA: Could you give us an idea of your current pipeline? BM: Calidi Biotherapeutics’ current pipeline consists of oncolytic… Read More

#Exclusive Content

#Biomanufacturing #Cell and gene therapy #Manufacturing

Collaboration aims to advance cell and gene therapy manufacturing  

A collaboration between a medical technology company and a non-profit group is aiming to advance the supply chain for cell and gene manufacturing in a bid to tackle scale-up and quality challenges within the sector.  Terumo Blood and Cell Technologies will work with GenCure to extend and… Read More

#News

#Appointment #Cell and gene therapy #Covid-19 #Diversity #HIV #Vaccines

This week in drug discovery (20-24 June)

News round-up by DDW’s Reece Armstrong for 20-24 June. Covid-19 vaccine development and research, gene therapies for dementia and a ‘game-changing’ treatment for HIV are some of the themes of this week’s news round-up. Moderna to set up mRNA vaccine centre in UK  Pharmaceutical company Moderna is to set-up… Read More

#News